BioMarin Pharmaceutical Inc. (BMV:BMRN)
Mexico · Delayed Price · Currency is MXN 992.10
0.00 (0.00%)
At close: Sep 30, 2025
BioMarin Pharmaceutical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| 3,064 | 2,854 | 2,419 | 2,096 | 1,846 | 1,860 | Upgrade | |
Revenue Growth (YoY) | 18.36% | 17.97% | 15.42% | 13.53% | -0.76% | 9.18% | Upgrade |
Cost of Revenue | 626.24 | 580.24 | 532.06 | 503.02 | 470.52 | 524.27 | Upgrade |
Gross Profit | 2,437 | 2,274 | 1,887 | 1,593 | 1,376 | 1,336 | Upgrade |
Selling, General & Admin | 958.48 | 1,009 | 892.41 | 823.24 | 759.38 | 737.67 | Upgrade |
Depreciation & Amortization Expenses | 24.35 | 43.26 | 62.21 | 67.19 | 69.93 | 66.66 | Upgrade |
Research & Development | 678.45 | 747.18 | 746.77 | 649.61 | 628.79 | 628.12 | Upgrade |
Other Operating Expenses | - | 10 | - | 108 | - | 52.82 | Upgrade |
Operating Income | 776.08 | 464.21 | 185.77 | -55.03 | -82.34 | -149.08 | Upgrade |
Interest Income | 73.57 | 74.88 | 58.34 | 18.03 | 10.48 | 16.61 | Upgrade |
Interest Expense | -11.09 | -12.67 | -17.34 | -15.97 | -15.34 | -29.31 | Upgrade |
Other Non-Operating Income (Expense) | 1.47 | -4.67 | -38.22 | -13.46 | 11.85 | 7.14 | Upgrade |
Total Non-Operating Income (Expense) | 63.96 | 57.55 | 2.79 | -11.4 | 6.99 | -5.56 | Upgrade |
Pretax Income | 840.04 | 521.76 | 188.56 | -66.42 | -75.35 | -154.64 | Upgrade |
Provision for Income Taxes | 182.8 | 114.9 | 20.92 | 8.02 | -11.27 | -903.03 | Upgrade |
Net Income | 657.24 | 426.86 | 167.65 | 141.56 | -64.08 | 854.03 | Upgrade |
Net Income to Common | 657.24 | 426.86 | 167.65 | 141.56 | -64.08 | 854.03 | Upgrade |
Net Income Growth | 156.15% | 154.62% | 18.43% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 191 | 190 | 188 | 185 | 183 | 181 | Upgrade |
Shares Outstanding (Diluted) | 197 | 197 | 192 | 189 | 183 | 192 | Upgrade |
Shares Change (YoY) | 1.98% | 2.67% | 1.39% | 3.34% | -4.61% | 7.06% | Upgrade |
EPS (Basic) | 3.44 | 2.25 | 0.89 | 0.76 | -0.35 | 4.72 | Upgrade |
EPS (Diluted) | 3.38 | 2.21 | 0.87 | 0.75 | -0.35 | 4.50 | Upgrade |
EPS Growth | 156.06% | 154.02% | 16.00% | - | - | - | Upgrade |
Free Cash Flow | 694.91 | 487.42 | 62.57 | 54.94 | 208.96 | -28.95 | Upgrade |
Free Cash Flow Growth | 42.57% | 679.02% | 13.88% | -73.71% | - | - | Upgrade |
Free Cash Flow Per Share | 3.53 | 2.48 | 0.33 | 0.29 | 1.14 | -0.15 | Upgrade |
Gross Margin | 79.56% | 79.67% | 78.01% | 76.00% | 74.52% | 71.82% | Upgrade |
Operating Margin | 25.33% | 16.27% | 7.68% | -2.63% | -4.46% | -8.01% | Upgrade |
Profit Margin | 21.45% | 14.96% | 6.93% | 6.75% | -3.47% | 45.90% | Upgrade |
FCF Margin | 22.68% | 17.08% | 2.59% | 2.62% | 11.32% | -1.56% | Upgrade |
EBITDA | 859.33 | 560.64 | 290.16 | 46.94 | 25.7 | -43.91 | Upgrade |
EBITDA Margin | 28.05% | 19.64% | 11.99% | 2.24% | 1.39% | -2.36% | Upgrade |
EBIT | 776.08 | 464.21 | 185.77 | -55.03 | -82.34 | -149.08 | Upgrade |
EBIT Margin | 25.33% | 16.27% | 7.68% | -2.63% | -4.46% | -8.01% | Upgrade |
Effective Tax Rate | 21.76% | 22.02% | 11.09% | -12.07% | 14.96% | 583.97% | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.